Legacy Private Trust Co. Amgen Inc Transaction History

Legacy Private Trust Co.

$1.46 Billion
Q3 2024

A detailed history of Legacy Private Trust Co. transactions in Amgen Inc stock. As of the latest transaction made, Legacy Private Trust Co. holds 6,932 shares of AMGN stock, worth $1.93 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

6,932

Previous 6,810 1.79%

Holding current value

$1.93 Million

Previous $2.13 Million 4.98%

% of portfolio

0.15%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$309.38 - $337.38 $37,744 - $41,160	122 Added 1.79%	6,932 $2.23 Million
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $44,667 - $54,282	-170 Reduced 2.44%	6,810 $2.13 Million
Q1 2024 Apr 10, 2024	BUY	$268.87 - $324.56 $1.25 Million - $1.51 Million	4,654 Added 200.09%	6,980 $1.98 Million
Q2 2023 Jul 07, 2023	SELL	$214.27 - $253.37 $17,998 - $21,283	-84 Reduced 3.49%	2,326 $516,000
Q1 2023 Apr 12, 2023	SELL	$225.79 - $275.2 $17,385 - $21,190	-77 Reduced 3.1%	2,410 $582,000
Q3 2022 Oct 06, 2022	SELL	$224.46 - $253.15 $12,345 - $13,923	-55 Reduced 2.16%	2,487 $561,000
Q1 2022 Apr 11, 2022	SELL	$219.27 - $242.57 $59,202 - $65,493	-270 Reduced 9.6%	2,542 $615,000
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $104,012 - $121,863	-490 Reduced 14.84%	2,812 $598,000
Q2 2021 Jul 09, 2021	SELL	$233.58 - $259.14 $50,686 - $56,233	-217 Reduced 6.17%	3,302 $805,000
Q1 2021 Apr 09, 2021	SELL	$221.91 - $258.6 $129,595 - $151,022	-584 Reduced 14.23%	3,519 $876,000
Q4 2020 Jan 12, 2021	SELL	$216.38 - $257.67 $417,613 - $497,303	-1,930 Reduced 31.99%	4,103 $943,000
Q3 2020 Oct 14, 2020	SELL	$234.65 - $260.95 $31,208 - $34,706	-133 Reduced 2.16%	6,033 $1.53 Million
Q2 2020 Jul 09, 2020	SELL	$197.81 - $242.74 $322,430 - $395,666	-1,630 Reduced 20.91%	6,166 $1.45 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $81,171 - $104,332	-429 Reduced 5.22%	7,796 $1.88 Million
Q3 2019 Oct 10, 2019	SELL	$174.11 - $208.62 $156,002 - $186,923	-896 Reduced 9.82%	8,225 $1.59 Million
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $97,686 - $114,510	-586 Reduced 6.04%	9,121 $1.68 Million
Q1 2019 Apr 11, 2019	BUY	$180.87 - $203.88 $148,856 - $167,793	823 Added 9.26%	9,707 $1.84 Million
Q4 2018 Jan 16, 2019	SELL	$178.4 - $208.25 $52,092 - $60,809	-292 Reduced 3.18%	8,884 $1.73 Million
Q3 2018 Oct 10, 2018	BUY	$185.29 - $208.89 $14,823 - $16,711	80 Added 0.88%	9,176 $1.9 Million
Q2 2018 Jul 13, 2018	SELL	$166.05 - $186.51 $17,435 - $19,583	-105 Reduced 1.14%	9,096 $1.68 Million
Q1 2018 Apr 13, 2018	BUY	$169.43 - $198.0 $203,993 - $238,392	1,204 Added 15.06%	9,201 $1.57 Million
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $53,168 - $59,405	315 Added 4.1%	7,997 $1.39 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $1.29 Million - $1.47 Million	7,682	7,682 $1.43 Million

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Private Trust Co., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Private Trust Co. with notifications on news.

Account

Legacy Private Trust Co. Amgen Inc Transaction History